Fig. 1From: Platelet-12 lipoxygenase targeting via a newly synthesized curcumin derivative radiolabeled with technetium-99mStructure of E26C, a human P-12-LOX inhibitor. It is a curcumin derivative with benzofuran ringBack to article page